S. Omahony et al., DETECTION OF C-KI-RAS MUTATIONS IN BILE SAMPLES FROM PATIENTS WITH PANCREATIC AND BILIARY CANCERS, JCP. Clinical molecular pathology, 48(6), 1995, pp. 316-318
Aim - To determine whether c-Ki-ras mutations can be detected in bile
from patients with biliary strictures caused by pancreatic cancer and
other biliary tumours, with a view to developing bile c-Ki-ras mutatio
ns as a non-invasive diagnostic marker of pancreatic cancer. Methods -
Bile was collected from 89 subjects (47 controls (including patients
with bile duct stones or benign stricture), 20 patients with pancreati
c cancer, 11 with cholangiocarcinoma, five with ampullary cancer, and
six with metastatic biliary obstruction) referred for endoscopic retro
grade cholangiopancreatography. DNA was extracted from bile and c-Ki-r
as codon 12 mutations were detected using PCR and a restriction enzyme
digestion method. Results - c-Ki-ras mutations were detected in 10 (5
0%) of 20 patients with pancreatic cancer, in one (9%) of 11 with chol
angiocarcinoma, and in two (33%) of six patients with metastatic bilia
ry obstruction (primary tumours: colon and prostate). C-Ki-ras mutatio
ns were not detected in the controls and patients with ampullary cance
r. Conclusions - The sensitivity of this test is too low at 50% to rec
ommend its use clinically, but with refinement has potential as a diag
nostic marker for pancreatic cancer.